Skip to content

The Latest Treatments for Alzheimer’s Disease

Treatment for Alzheimer's disease, the devastating condition that affects more than five million Americans, has remained notoriously elusive for decades. Now, a small study released by drug company Eli Lilly offers at least a flicker of hope: It shows that the experimental drug donanemab may significantly slow patients’ cognitive decline.
Read More

Do Seniors with Dementia Show Signs of Financial ‘Symptoms’ Years before a Diagnosis?

A new study led by researchers at the Johns Hopkins Bloomberg School of Public Health and the Federal Reserve Board of Governors found that Medicare beneficiaries who go on to be diagnosed with dementia are more likely to miss payments on bills, as early as six years before a clinical diagnosis.
Read More
Back To Top